BioCentury
ARTICLE | Emerging Company Profile

Simcha launches with $25M WuXi-led series A, new take on IL-18 for cancer

With IP from a Yale lab, Simcha hopes its IL-18 variant will circumvent a resistance mechanism in tumors

June 25, 2020 2:06 AM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article